Biotricity (BTCY) Stock Price, News & Analysis

Company Overview

Biotricity Inc. is a medical technology company focused on remote cardiac monitoring and connected healthcare. The company develops and provides technology designed to help physicians monitor patients outside traditional clinical settings, with the goal of supporting the diagnosis and management of cardiac conditions.

Its product portfolio includes wearable and mobile cardiac-monitoring solutions such as Bioflux, a real-time ambulatory cardiac monitoring system, and Biotres, a remote monitoring platform intended to support longer-term cardiac care. Biotricity also provides related software, data-management tools, and monitoring services that connect patients, healthcare providers, and clinical information.

Founded in 2013, Biotricity primarily serves healthcare providers and patients in the United States through its remote patient-monitoring and medical-device offerings. The company was founded and is led by Waqaas Al-Siddiq, who serves as chief executive officer.

Key Stats

• Today's Range: $0.05 to $0.05
• 50-Day Range: $0.04 to $0.13
• 52-Week Range: $0.04 to $0.70
• Volume: 10,000 shs
• Average Volume: 51,982 shs
• Market Capitalization: $1.00 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 2/11/2026
• Today: 10/16/2026
• Next Earnings (Estimated): 11/12/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:BTCY
• Previous Symbol: OTCMKTS:BTCY
• CIK: 1630113
• Web: www.biotricity.com
• Phone: (800) 590-4155
• Fax: N/A
• Employees: 46
• Year Founded: 2014

Profitability

• EPS (Trailing Twelve Months): ($0.14)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$14.09 million
• Net Margins: -80.42%
• Pretax Margin: -80.42%
• Return on Equity: N/A
• Return on Assets: -188.47%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.23
• Quick Ratio: 0.10

Sales & Book Value

• Annual Sales: $12.06 million
• Price / Sales: 0.08
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.30) per share
• Price / Book: -0.04

Miscellaneous

• Outstanding Shares: 20,075,000
• Free Float: 22,075,000
• Market Cap: $1.00 million
• Optionable: No Data
• Beta: 1.21